miR-181c-5p/DERL1 pathway controls breast cancer progression mediated by TRAF6-linked K63 ubiquitination of AKT.

导出 OA

翻译打印收藏纠错

第一作者： Yang,Bai

第一单位： Laboratory of Department of Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.

作者： Yang,Bai ^[1] ; Zhanqiang,Zhang ^[2] ; Jiong,Bi ^[1] ; Qian,Tang ^[3] ; Keying,Jiang ^[1] ; Chen,Yao ^[1] ; Wenjian,Wang ^[4]

作者单位： Laboratory of Department of Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China. ^[1] Department of Thyroid, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China. ^[2] Department of Anesthesiology, Guiqian International General Hospital, Guiyang, 550000, Guizhou, China. ^[3] Laboratory of Department of Surgery, the First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China. wangwj28@mail.sysu.edu.cn. ^[4]

关键词 Breast cancer DERL1 K63-ubiquitination Micro RNA Prognosis

DOI 10.1186/s12935-024-03395-1

PMID 38858669

发布时间 2024-06-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交